Ontology highlight
ABSTRACT:
OTHER RELATED OMICS DATASETS IN: E-MTAB-2706
PROVIDER: EGAO00000001052 | EGA |
REPOSITORIES: EGA
Mariathasan Sanjeev S Turley Shannon J SJ Nickles Dorothee D Castiglioni Alessandra A Yuen Kobe K Wang Yulei Y Kadel Edward E EE Koeppen Hartmut H Astarita Jillian L JL Cubas Rafael R Jhunjhunwala Suchit S Banchereau Romain R Yang Yagai Y Guan Yinghui Y Chalouni Cecile C Ziai James J Şenbabaoğlu Yasin Y Santoro Stephen S Sheinson Daniel D Hung Jeffrey J Giltnane Jennifer M JM Pierce Andrew A AA Mesh Kathryn K Lianoglou Steve S Riegler Johannes J Carano Richard A D RAD Eriksson Pontus P Höglund Mattias M Somarriba Loan L Halligan Daniel L DL van der Heijden Michiel S MS Loriot Yohann Y Rosenberg Jonathan E JE Fong Lawrence L Mellman Ira I Chen Daniel S DS Green Marjorie M Derleth Christina C Fine Gregg D GD Hegde Priti S PS Bourgon Richard R Powles Thomas T
Nature 20180214 7693
Therapeutic antibodies that block the programmed death-1 (PD-1)-programmed death-ligand 1 (PD-L1) pathway can induce robust and durable responses in patients with various cancers, including metastatic urothelial cancer. However, these responses only occur in a subset of patients. Elucidating the determinants of response and resistance is key to improving outcomes and developing new treatment strategies. Here we examined tumours from a large cohort of patients with metastatic urothelial cancer wh ...[more]